Pain is the most common 24 (75%) of whom were women. The mean duration of night sedation was 43'9 months. Fourteen patients were receiving night sedation for insomnia related to pain, all but one of whom were women. There was no significant difference in the age of those receiving night sedation (57 3 years) and those not (63-2 years) (t=0 341). Table 2 shows that about one third of patients receiving tricyclic drugs or codeine were also receiving night sedation. Although there was no significant difference in the use of non-steroidal anti-inflammatory drugs (NSAIDs) between those using night sedation and those not the analgesia produced by narcotics (codeine was usually taken in compound form with paracetamol such as co-codamol or co-dydramol) was used by significantly more (34%) of those receiving night sedation than those not (19%) (table 2) . It was difficult, however, to determine whether tricyclic drug treatment was primarily prescribed for reactive depression or for central analgesia effect because most patients had been receiving these drugs over a long period of time.
Night pain and sleep disturbance in patients with arthritis require full attention and a multidisciplinary team management approach.
Effective communication is essential between the patient and the team. Any evidence of anxiety or depression through the course of the disease should first be tackled with counselling. As night sedation is often prescribed for insomnia associated with pain, modification of the NSAID/analgesic regimen should be tried first. Nefopam (Acupan) is often a useful analgesic and has the advantage of not causing habituation.3 One of us (PH) has found it useful in combination with NSAIDs.
The unnecessary prescribing of benzodiazepine carries the risk of dependency with knock-on effects in lost working capacity due to side effects and their treatment. 4 The number of patients seeking damages for the symptoms of addiction and of withdrawal from these drugs is growing.5 In our study the duration of night sedation varied from six weeks up to 14 years (mean 43-9 months) which indicates that many patients were becoming addicted to these drugs. Although a plan to withdraw hypnotic drug treatment was not part of the current project, elsewhere the introduction of such a policy to withdraw psychotropic drugs with the support of a specially trained practice nurse has shown some success. 6 Developing a drug audit in patients with rheumatic diseases appears to be a useful and informative first step in highlighting these problems. 
